Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 1
2010 1
2011 2
2013 1
2018 1
2019 2
2020 2
2021 5
2022 4
2023 1
2024 2
2025 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

22 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean ahmadi a[au] (1,733 results)?
Mitragyna Species as Pharmacological Agents: From Abuse to Promising Pharmaceutical Products.
Ahmad I, Prabowo WC, Arifuddin M, Fadraersada J, Indriyanti N, Herman H, Purwoko RY, Nainu F, Rahmadi A, Paramita S, Kuncoro H, Mita N, Narsa AC, Prasetya F, Ibrahim A, Rijai L, Alam G, Mun'im A, Dej-Adisai S. Ahmad I, et al. Among authors: rahmadi a. Life (Basel). 2022 Jan 27;12(2):193. doi: 10.3390/life12020193. Life (Basel). 2022. PMID: 35207481 Free PMC article. Review.
Does MAFLD really increase the severity of COVID-19?
Fajar JK, Wibowo BP, Dewi GC, Rahmadi AP, Kusuma MT. Fajar JK, et al. Among authors: rahmadi ap. Dig Liver Dis. 2021 Feb;53(2):166-167. doi: 10.1016/j.dld.2020.10.042. Epub 2020 Nov 11. Dig Liver Dis. 2021. PMID: 33208296 Free PMC article. No abstract available.
A phase III, observer-blind, randomized, placebo-controlled study of the efficacy, safety, and immunogenicity of SARS-CoV-2 inactivated vaccine in healthy adults aged 18-59 years: An interim analysis in Indonesia.
Fadlyana E, Rusmil K, Tarigan R, Rahmadi AR, Prodjosoewojo S, Sofiatin Y, Khrisna CV, Sari RM, Setyaningsih L, Surachman F, Bachtiar NS, Sukandar H, Megantara I, Murad C, Pangesti KNA, Setiawaty V, Sudigdoadi S, Hu Y, Gao Q, Kartasasmita CB. Fadlyana E, et al. Among authors: rahmadi ar. Vaccine. 2021 Oct 22;39(44):6520-6528. doi: 10.1016/j.vaccine.2021.09.052. Epub 2021 Sep 24. Vaccine. 2021. PMID: 34620531 Free PMC article. Clinical Trial.
Immunogenicity and safety of Quadrivalent Influenza HA vaccine compared with Trivalent Influenza HA vaccine and evaluation of Quadrivalent Influenza HA vaccine batch-to-batch consistency in Indonesian children and adults.
Fadlyana E, Dhamayanti M, Tarigan R, Prodjosoewojo S, Rahmadi AR, Sari RM, Rusmil K, Kartasasmita CB. Fadlyana E, et al. Among authors: rahmadi ar. PLoS One. 2023 Aug 24;18(8):e0281566. doi: 10.1371/journal.pone.0281566. eCollection 2023. PLoS One. 2023. PMID: 37616221 Free PMC article. Clinical Trial.
22 results